Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OTC NSAID use linked to increased risk of gastrointestinal bleeding in ACG's GI Registry.

This article was originally published in The Tan Sheet

Executive Summary

OTC NSAID LINK TO GI BLEEDING SUPPORTED BY DATA FROM GI REGISTRY developed by the American College of Gastroenterology under a grant from McNeil Consumer Products. Early data from the GI Registry -- essentially a physician survey that uses a control group for comparisons -- was presented at ACG's annual scientific meeting Oct. 16 in New York City.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS084419

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel